Dolutegravir Plus Lamivudine as a Switch Strategy Dolutegravir Plus Lamivudine as a Switch Strategy

A new study provides valuable insight into the safety and long-term efficacy of this combination regimen as a switch strategy in HIV patients.JAIDS: Journal of Acquired Immune Deficiency Syndromes
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news